top of page
Concept illustration
MitraMag:
Next-generation
bioresorbable
implant
against
infective
endocarditis
A bioresorbable cardiac implant under development to inhibit bacterial adhesion, reduce infection recurrence, and eliminate long-term foreign body risk
Bioresorbable Core Structure
ZX00 (magnesium alloy).
Ensures mechanical strengthening of the heart valve annulus while providing full bioresorption ability
Matrix-Shell For Agent Control
Electrospun polycaprolactone (PCL).
A structural shell for the precise embedding and regulation of the active substance
MitraMag, a bioresorbable annuloplastic implant:
A dual-component antimicrobial treatment technology
Concept illustration
MitraMag Prototype
Local Antimicrobial Agent
0.5 wt% silver nanoparticles (AgNPs).
Silver nanoparticles embedded in the PCL matrix release Ag ions and thus form an efficient barrier against biofilm formation.
Current Technological Readiness Level
News updates
The founder’s team #Bruno Podesser, #Helga Bergmeister, #Wolfgang Tuechler, #Manfred Bammer of CardEvo is very proud to share that our start-up, a spin-off of the Medizinische Universität Wien, has been chosen as one of the Falling Walls Venture TOP 100 Science Start-ups to Watch in 2026 by Falling Walls Foundation!
🚀 This recognition highlights our work in developing a bioresorbable annuloplasty ring for mitral valve repair, while delivering local antibacterial therapy in order to break the wall of infective endocarditis in heart valves.
bottom of page